Which of the following drugs is NOT used to prevent contrast nephropathy?
Which contrast agent is typically used for Magnetic Resonance Imaging (MRI)?
Which of the following contrast agents is preferred in a patient with decreased renal function to avoid contrast nephropathy?
Contrast-induced nephropathy is defined as a rise in serum creatinine by:
What contrast dye(s) are used in MRI?
Which of the following is a non-iodinated contrast agent?
A patient is to undergo angiography for unstable angina and has an elevated serum creatinine. Which of the following measures is NOT used to prevent contrast nephropathy?
Allergic-like reactions to radiological contrast agents are predominantly:
Which of the following investigations must be performed before giving the agent shown to a patient?

Iodine particle ratio for Ionic dimer is
Explanation: **Explanation:** **Contrast-Induced Nephropathy (CIN)** is a form of acute kidney injury occurring after the administration of iodinated contrast. The primary pathophysiology involves renal vasoconstriction and direct tubular toxicity. **Why Fenoldopam is the correct answer:** Fenoldopam is a selective dopamine-1 (D1) receptor agonist that causes systemic and renal vasodilation. While theoretically beneficial for increasing renal blood flow, multiple large-scale clinical trials (such as the CONTRAST study) have proven that **Fenoldopam is NOT effective** in preventing CIN. In some cases, it may even worsen outcomes by causing systemic hypotension, which reduces renal perfusion pressure. **Analysis of other options:** * **N-acetylcysteine (NAC):** An antioxidant that scavenges free radicals and may cause vasodilation. While its efficacy is debated in recent literature, it remains a classically taught prophylactic agent in medical exams. * **Infusion of Normal Saline:** This is the **most effective** and gold-standard preventive measure. Volume expansion helps by diluting the contrast media, maintaining high tubular flow, and suppressing the renin-angiotensin-aldosterone system. * **Hemodialysis:** While not a routine prophylactic measure for all patients, it is used in specific high-risk scenarios (like end-stage renal disease) to clear contrast. However, in the context of this question, Fenoldopam is the definitive "non-indicated" drug. **High-Yield Clinical Pearls for NEET-PG:** * **Definition of CIN:** An increase in serum creatinine of >0.5 mg/dL or >25% from baseline within 48–72 hours of contrast exposure. * **Best Prevention:** Isotonic saline (0.9% NaCl) or Sodium Bicarbonate infusion. * **Risk Factor:** Pre-existing renal insufficiency (especially Diabetic Nephropathy) is the strongest risk factor. * **Contrast Type:** Low-osmolar (LOCM) or Iso-osmolar contrast media (IOCM) are preferred over high-osmolar agents to reduce risk.
Explanation: **Explanation:** **1. Why Gadolinium is Correct:** Gadolinium (Gd³⁺) is a rare-earth heavy metal and the gold standard contrast agent for MRI. Its primary mechanism of action is **paramagnetism**. Gadolinium ions have seven unpaired electrons, which create a local magnetic field that shortens the **T1 relaxation time** of nearby water protons. This results in a "positive" contrast effect, appearing as **hyperintensity (bright signal)** on T1-weighted images. Because free gadolinium is toxic, it is always administered in a **chelated form** (e.g., Gadopentetate dimeglumine) to ensure safe renal excretion. **2. Why the Other Options are Incorrect:** * **A. Iodine:** This is the basis for CT and fluoroscopy contrast. Iodine attenuates X-rays due to its high atomic number but does not possess the paramagnetic properties required for MRI. * **C. Metrazamide:** This is an older, first-generation non-ionic water-soluble iodinated contrast medium primarily used for myelography in the past. It is not used in MRI. * **D. Omnipaque (Iohexol):** This is a commonly used low-osmolar, non-ionic **iodinated contrast** agent used for CT scans and angiography. **3. High-Yield Clinical Pearls for NEET-PG:** * **Nephrogenic Systemic Fibrosis (NSF):** A rare but serious complication of gadolinium use in patients with severe renal failure (GFR < 30 mL/min). Linear chelates pose a higher risk than macrocyclic chelates. * **Excretion:** Gadolinium is primarily excreted via the kidneys; however, Primovist (Eovist) is a hepatobiliary agent excreted via both bile and urine. * **Safety:** MRI contrast does not contain iodine, making it a safe alternative for patients with documented true anaphylaxis to iodinated (CT) contrast.
Explanation: **Explanation:** Contrast-Induced Nephropathy (CIN) is a significant risk in patients with pre-existing renal impairment. The primary mechanism of injury involves direct tubular toxicity and renal medullary ischemia. **Why Option D is Correct:** The risk of CIN is directly proportional to the **osmolality** of the contrast agent. High-osmolar contrast media (HOCM) cause significant osmotic diuresis and vasoconstriction. **Low-osmolar contrast media (LOCM)** (e.g., Iohexol, Iopromide) and **Iso-osmolar contrast media (IOCM)** (e.g., Iodixanol) are significantly less nephrotoxic and are the preferred agents for patients with a low GFR to minimize the risk of acute kidney injury. **Why Other Options are Incorrect:** * **A. Acetylcysteine:** While once widely used for its antioxidant properties to prevent CIN, recent large-scale trials (like the PRESERVE trial) have shown it provides no definitive clinical benefit over hydration alone. * **B. Fenoldopam:** A dopamine receptor agonist intended to increase renal blood flow; however, clinical studies have failed to show it prevents CIN. * **C. Mannitol:** An osmotic diuretic that was previously thought to "flush" the kidneys. It is now known that diuretics can actually worsen CIN by causing volume depletion and are **contraindicated** for CIN prophylaxis. **NEET-PG High-Yield Pearls:** 1. **Most Effective Prophylaxis:** The single most important step to prevent CIN is **adequate intravenous hydration** (Normal Saline or Sodium Bicarbonate) before and after the procedure. 2. **Risk Factor:** A baseline Serum Creatinine >1.5 mg/dL or eGFR <60 mL/min/1.73m² identifies high-risk patients. 3. **Metformin Rule:** Metformin does not cause CIN, but if CIN occurs, Metformin can accumulate and cause **Lactic Acidosis**. It should be withheld for 48 hours after the procedure in high-risk patients.
Explanation: **Explanation:** **Contrast-Induced Nephropathy (CIN)** is a form of acute kidney injury occurring after the intravenous or intra-arterial administration of iodinated contrast media, in the absence of an alternative etiology. The correct answer is **A (0.5 mg/dL within 48 hours)** because the most widely accepted clinical definition of CIN is: 1. An absolute increase in serum creatinine of **≥0.5 mg/dL** (44 µmol/L) from baseline, **OR** 2. A relative increase of **≥25%** from the baseline value. These changes typically occur within **48 to 72 hours** after contrast exposure. The pathophysiology involves a combination of direct tubular toxicity and renal medullary ischemia due to vasoconstriction. **Why the other options are incorrect:** * **Options B, C, and D:** While these represent higher levels of creatinine elevation, they are not the *minimum* threshold required for the diagnosis. Using a threshold of 1.0 mg/dL or higher would lead to significant underdiagnosis of early-stage acute kidney injury, delaying necessary clinical intervention. **High-Yield Clinical Pearls for NEET-PG:** * **Risk Factors:** Pre-existing chronic kidney disease (CKD) and Diabetes Mellitus are the most significant risk factors. * **Prevention:** The most effective preventive strategy is **adequate hydration** (usually with 0.9% Normal Saline) before and after the procedure. * **Contrast Choice:** Low-osmolar (LOCM) or iso-osmolar contrast media (IOCM) are preferred over high-osmolar agents to reduce risk. * **Metformin:** It does not cause CIN, but if CIN occurs, metformin can accumulate and cause **lactic acidosis**. It should be withheld for 48 hours after the procedure in high-risk patients.
Explanation: **Explanation:** **Gadolinium (Option A)** is the correct answer because it is a paramagnetic substance. In MRI, contrast agents work by shortening the T1 relaxation time of water protons in the surrounding tissues, which results in a "bright" signal (T1 shortening effect). Gadolinium is a rare earth metal that is toxic in its free state; therefore, it is always administered as a **chelate** (e.g., Gd-DTPA) to ensure safety and renal excretion. **Analysis of Incorrect Options:** * **Iodine (Option B):** Iodinated contrast media are used in **CT scans and Fluoroscopy**. They work by increasing the attenuation of X-rays due to the high atomic number of iodine. They are not used in MRI as they do not possess paramagnetic properties. * **Myodinium (Option C):** This is a distractor and not a recognized medical contrast agent. * **Technetium (Option D):** Technetium-99m is a **radioisotope** used in Nuclear Medicine (e.g., Bone scans, SPECT). It emits gamma radiation for detection by a gamma camera, rather than altering magnetic relaxation. **High-Yield Clinical Pearls for NEET-PG:** 1. **Nephrogenic Systemic Fibrosis (NSF):** A rare but serious complication of Gadolinium use in patients with severe renal failure (GFR < 30 mL/min). 2. **Safety:** Gadolinium is generally safer than iodinated contrast regarding anaphylactoid reactions, but it is contraindicated in pregnancy unless the benefit clearly outweighs the risk. 3. **Hepatobiliary Agents:** Gadoxetate disodium (Primovist/Eovist) is a specific Gadolinium chelate used for functional imaging of the liver.
Explanation: ### Explanation **Correct Answer: A. Gadolinium** **Concept:** Contrast agents are classified based on their chemical composition and the imaging modality used. **Gadolinium-based contrast agents (GBCAs)** are paramagnetic metallic complexes used exclusively in **Magnetic Resonance Imaging (MRI)**. Unlike CT contrast agents, they do not contain iodine; instead, they work by shortening the T1 relaxation time of water protons in the body to enhance image signal. **Analysis of Incorrect Options:** * **B. Visipaque (Iodixanol):** This is a non-ionic, **iso-osmolar iodinated** contrast agent (IOCM). It is frequently highlighted in exams for having the same osmolality as blood (290 mOsm/kg), making it safer for patients with renal impairment. * **C. Iopamidol:** This is a non-ionic, **low-osmolar iodinated** contrast agent (LOCM). It is commonly used in CT scans and angiography. * **D. Diatrizoate:** This is an ionic, **high-osmolar iodinated** contrast agent (HOCM). Due to its high osmolality and increased risk of adverse reactions, its intravenous use has largely been replaced by LOCMs. **High-Yield Clinical Pearls for NEET-PG:** * **Nephrogenic Systemic Fibrosis (NSF):** A rare but serious systemic complication of Gadolinium use in patients with severe renal failure (GFR < 30 mL/min). * **Contrast-Induced Nephropathy (CIN):** Primarily associated with **iodinated** contrast (CT), not Gadolinium. * **Drug of Choice for History of Allergy:** If a patient is severely allergic to iodinated contrast, MRI with Gadolinium is often the preferred alternative imaging modality. * **Safety:** Non-ionic agents (like Iopamidol) are safer and cause fewer anaphylactoid reactions than ionic agents (like Diatrizoate).
Explanation: **Explanation:** Contrast-Induced Nephropathy (CIN) is a significant risk in patients with pre-existing renal impairment undergoing procedures like angiography. The management focuses on volume expansion and minimizing oxidative stress. **Why Fenoldopam is the correct answer:** Fenoldopam is a selective dopamine D1 receptor agonist that causes systemic and renal vasodilation. While theoretically beneficial for renal blood flow, multiple large-scale clinical trials (such as the CONTRAST study) have proven that it **does not reduce the risk of CIN**. Therefore, it is not recommended for prophylaxis. **Analysis of other options:** * **0.9% Saline (Isotonic Hydration):** This is the **most effective** and gold-standard preventive measure. Hydration increases tubular flow, dilutes the contrast media, and prevents renal vasoconstriction. * **N-acetylcysteine (NAC):** An antioxidant that scavenges free radicals and may cause vasodilation. While its efficacy is debated in recent literature (ACT trial), it is still frequently used in clinical practice and remains a standard textbook answer for CIN prevention. * **Haemofiltration:** Peri-procedural continuous venovenous haemofiltration in an ICU setting has been shown to be effective in high-risk patients by removing contrast and maintaining fluid balance, though it is invasive and expensive. **High-Yield Clinical Pearls for NEET-PG:** * **Definition of CIN:** An increase in serum creatinine >0.5 mg/dL or >25% from baseline within 48–72 hours of contrast administration. * **Best Preventive Measure:** Intravenous hydration with 0.9% Normal Saline (1 mL/kg/hr for 12 hours before and after the procedure). * **Contrast Choice:** Use **Non-ionic, Low-osmolar (LOCM)** or **Iso-osmolar** contrast media to reduce risk. * **Drugs to avoid:** Metformin should be withheld for 48 hours after the procedure to prevent lactic acidosis if renal failure occurs. * **Ineffective drugs:** Diuretics (Furosemide), Mannitol, and Dopamine are **not** used for CIN prevention and may actually worsen it.
Explanation: **Explanation:** **1. Why Anaphylactoid reactions is correct:** Allergic-like reactions to iodinated contrast media are termed **anaphylactoid (or pseudo-allergic)** because they clinically mimic true anaphylaxis but do not require prior sensitization. Unlike true allergies, these reactions result from the **direct release of histamine** and other mediators from mast cells and basophils, or the activation of the complement system, rather than an IgE-mediated mechanism. Because they are not dose-dependent and can occur on the very first exposure, "anaphylactoid" is the most accurate classification. **2. Why other options are incorrect:** * **B. IgE-mediated reactions:** True anaphylaxis is IgE-mediated and requires a prior sensitizing exposure. Most contrast reactions occur without prior exposure, making this mechanism rare for radiological agents. * **C. Urticaria & D. Angioedema:** These are specific **clinical manifestations** (symptoms) of a reaction, not the underlying physiological mechanism. While urticaria is the most common skin manifestation, the question asks for the predominant *nature* of the reaction. **3. Clinical Pearls for NEET-PG:** * **Risk Factors:** A history of previous contrast reaction is the strongest predictor. Asthma and significant food/drug allergies also increase risk, but **seafood/shellfish allergy is NOT a specific predictor** for contrast reactions. * **Pre-medication:** For high-risk patients, corticosteroids (e.g., Prednisolone) and H1-blockers are used. * **Treatment of Choice:** For severe anaphylactoid reactions (bronchospasm/hypotension), the drug of choice is **Adrenaline (1:1000 IM)**. * **Non-ionic vs. Ionic:** Non-ionic, low-osmolar contrast media (LOCM) have a significantly lower incidence of adverse reactions compared to high-osmolar ionic agents.
Explanation: ***Serum creatinine*** - The image shows Omniscan (gadodiamide) Injection, which is a **gadolinium-based contrast agent (GBCA)** used in MRI. - GBCAs are primarily excreted by the kidneys, so assessing **renal function** via serum creatinine is crucial to prevent **nephrogenic systemic fibrosis (NSF)** in patients with severe renal impairment. *C3 levels* - **C3 levels** are typically used to evaluate the **complement system**, which is involved in immune responses and conditions like **lupus nephritis** or **glomerulonephritis**. - They are not relevant for assessing **renal clearance** before administering gadolinium-based contrast. *Urine specific gravity* - **Urine specific gravity** measures the urine's concentration, indicating the kidneys' ability to conserve or excrete water. - While it gives some insight into renal function, a **serum creatinine** provides a more direct and accurate measure of **glomerular filtration rate (GFR)**, which is essential for GBCA administration guidelines. *Serum electrolytes* - **Serum electrolytes** (e.g., sodium, potassium) are important for assessing **fluid balance** and various metabolic functions. - While electrolyte imbalances can be associated with **renal dysfunction**, checking these levels alone is not the primary or most direct investigation required to assess the risk of **GBCA-induced nephrotoxicity** or NSF.
Explanation: ***6:2*** - An **ionic dimer** contrast agent contains **six iodine atoms** (three on each monomer unit) and **two osmotically active particles** in solution (one dimer anion and one counter-cation such as sodium or meglumine). - This results in a ratio of **6 iodine atoms** to **2 osmotically active particles**, giving an iodine-to-particle ratio of **6:2** (or 3:1 when simplified). *6:1* - This ratio would imply that for six iodine atoms, there is only **one osmotically active particle**, which is not correct for an ionic dimer. - Ionic dimers dissociate into **two particles** (the dimer anion and its counter-cation), so a 6:1 ratio is chemically incorrect for this type of contrast agent. *3:2* - This ratio accurately describes an **ionic monomer**, not an ionic dimer. - An ionic monomer has **three iodine atoms** and dissociates into **two particles**, giving a 3:2 ratio. - An ionic dimer has **six iodine atoms** (double that of a monomer), making this ratio incorrect for ionic dimers. *2:6* - This ratio is the inverse of the correct answer and implies **fewer iodine atoms** than osmotically active particles, which is physically impossible. - An ionic dimer has **more iodine atoms** (6) than osmotically active particles (2), making this ratio completely incorrect.
Chemistry of Contrast Media
Practice Questions
Pharmacokinetics of Contrast Agents
Practice Questions
Classification of Contrast Reactions
Practice Questions
Risk Factors for Contrast Reactions
Practice Questions
Prevention of Contrast Reactions
Practice Questions
Treatment of Acute Contrast Reactions
Practice Questions
Contrast-Induced Nephropathy
Practice Questions
Nephrogenic Systemic Fibrosis
Practice Questions
Extravasation of Contrast Media
Practice Questions
Guidelines for Contrast Administration
Practice Questions
Alternative Contrast Agents
Practice Questions
Documentation and Medicolegal Aspects
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free